======= TCEAL7 =======
== Gene Information ==
* **Official Symbol**: TCEAL7
* **Official Name**: transcription elongation factor A like 7
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56849|56849]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BRU2|Q9BRU2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TCEAL7&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TCEAL7|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/300771|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Plays a role in the negative regulation of NF-kappa-B signaling at the basal level by modulating transcriptional activity of NF-kappa-B on its target gene promoters. Associates with cyclin D1 promoter containing Myc E-box sequence and transcriptionally represses cyclin D1 expression. Regulates telomerase reverse transcriptase expression and telomerase activity in both ALT (alternative lengthening of telomeres)and telomerase-positive cell lines. {ECO:0000269|PubMed:18806825, ECO:0000269|PubMed:19966855, ECO:0000269|PubMed:20454512}.
|BEX|
|WW domain binding|
|negative regulation of NF-kappaB transcription factor activity|
|negative regulation of DNA-binding transcription factor activity|
|regulation of DNA-binding transcription factor activity|
|negative regulation of molecular function|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-1.91|
|[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-1.83|
|[[:results:exp112|S-DABN 8μM R03 exp112]]|-1.79|
|[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|-1.78|
|[[:results:exp528|TGF-beta1 44ng/ml R08 exp528]]|-1.72|
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.7|
|[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|1.78|
|[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|1.95|
|[[:results:exp242|Radicicol 0.16μM R05 exp242]]|2.37|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/683
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/26|
|bone|0/25|
|breast|0/30|
|central nervous system|0/49|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/11|
|fibroblast|0/1|
|gastric|0/14|
|kidney|0/18|
|liver|0/19|
|lung|0/72|
|lymphocyte|0/14|
|ovary|0/25|
|pancreas|0/22|
|peripheral nervous system|0/15|
|plasma cell|0/12|
|prostate|0/1|
|skin|0/20|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/28|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13335
* **Expression level (log2 read counts)**: -3.28
{{:chemogenomics:nalm6 dist.png?nolink |}}